Condition

Neuroprotection

ClinicalTrials.gov condition label

Clinical trials3

Recruiting1

Common interventions5

Lead sponsors shown3

Clinical trials

3 shown

Evaluation of BRUDYGLAUCO (DHA + Citicoline) in Patients With GlaucomaNCT07322965 · 2025-04-01

RECRUITING

Effect of Fixed Combination Citicoline Homotaurine and Pyrroloquinoline Quinone on Pattern-electroretinogram in GlaucomaNCT06431113 · 2024-01-27

COMPLETED

Neuroprotective Effects of iTBS in PDNCT05445505 · 2022-08-01

UNKNOWN

Common interventions

BrudyGlaucoDIETARY_SUPPLEMENT1Citicoline 500 mg plus Homotaurine 50 mg plus Pyrroloquinoline quinone (Neuprozin Mito® )COMBINATION_PRODUCT1intermittent theta burst stimulationDEVICE1PlaceboDIETARY_SUPPLEMENT1sham iTBSDEVICE1

Leading sponsors

Fondazione IRCCS Policlinico San Matteo di Pavia1Institut Catala de Retina1Ruijin Hospital1

Trial status mix

COMPLETED1

RECRUITING1

UNKNOWN1

Phase mix

NA2

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.